Periurethral Vascular Hamartoma in a 6-Month-Old Foal With Idiopathic Hematuria: New Differential Diagnosis

Periurethral Vascular Hamartoma in a 6-Month-Old Foal With Idiopathic Hematuria: New Differential Diagnosis

Accepted Manuscript Periurethral vascular hamartoma in a 6-month-old foal with idiopathic hematuria: new differential diagnosis Nicolas I. Busse, DVM,...

1MB Sizes 0 Downloads 3 Views

Accepted Manuscript Periurethral vascular hamartoma in a 6-month-old foal with idiopathic hematuria: new differential diagnosis Nicolas I. Busse, DVM, Enrique A. Paredes, DVM, Dr. Vet. Med., Hedie A. Bustamante, DVM, PhD, Nicolás Ansoleaga, DVM, Benjamín Uberti, DVM, MS PII:

S0737-0806(18)30004-2

DOI:

10.1016/j.jevs.2018.02.017

Reference:

YJEVS 2473

To appear in:

Journal of Equine Veterinary Science

Received Date: 4 January 2018 Revised Date:

22 February 2018

Accepted Date: 22 February 2018

Please cite this article as: Busse NI, Paredes EA, Bustamante HA, Ansoleaga N, Uberti B, Periurethral vascular hamartoma in a 6-month-old foal with idiopathic hematuria: new differential diagnosis, Journal of Equine Veterinary Science (2018), doi: 10.1016/j.jevs.2018.02.017. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT 1

Title:

2

Periurethral vascular hamartoma in a 6-month-old foal with idiopathic hematuria: new

3

differential diagnosis

Nicolas I. Busse, DVMa

6

Enrique A. Paredes, DVM, Dr. Vet. Med.b

7

Hedie A. Bustamante, DVM, PhDa

8

Nicolás Ansoleaga, DVMa

9

Benjamín Uberti, DVM, MSa

M AN U

10

SC

5

RI PT

4

From the aInstitute of Veterinary Clinical Sciences, bInstitute of Animal Pathology, College of

12

Veterinary Sciences, Universidad Austral de Chile, Valdivia, Chile, 5090000

13

Address: Universidad Austral de Chile, Independencia 641, Valdivia, Chile, 5090000

EP

15

Corresponding author: Dr. Benjamin Uberti ([email protected]).

AC C

14

TE D

11

ACCEPTED MANUSCRIPT Abstract:

17

Hamartomas are non-malignant masses of normal tissue organized in a chaotic manner. Here,

18

we describe a 6-month-old 120 kg Chilean Criollo foal that manifested chronic hematuria

19

observed since birth. Severe anemia and lack of development were the main complaints of

20

this referral. The foal was depressed, in poor body condition, had lagged development and a

21

coarse haircoat. Mucous membranes were pale and numerous blood clots were observed

22

towards the end of micturition. Severe normocytic normochromic anemia was confirmed by

23

hematological analysis; there were no significant findings in serum biochemistry or

24

coagulation tests. Transabdominal ultrasonography and urinary tract endoscopy yielded no

25

clinically relevant results. Empirical treatment was initiated on a tentative diagnosis of

26

idiopathic renal hematuria (dexamethasone 0.1 mg/kg [0.045 mg/lb], q 24 h, IV, sodium

27

ceftiofur 2.2 mg/kg [0.99 mg/lb], IM, q 24 h, blood transfusions), but the foal’s condition

28

further deteriorated, warranting euthanasia. Necropsy revealed a vascular malformation on the

29

extraluminal portion of the proximal urethra at the bladder junction, with a 3 mm urethral

30

communication. Histopathologic examination confirmed this mass to be a hamartoma of

31

vascular origin, which incidentally communicated with the urethral lumen and led to

32

progressive blood loss. In this case, the location of this malformation impeded its discovery

33

and ultimately an accurate diagnosis. Hamartomas are currently not listed as a differential

34

diagnosis for bleeding-related urinary tract disorders in the modern literature, thus we propose

35

that they should be considered as a differential diagnosis in cases of unexplained or refractory

36

idiopathic hematuria.

37

Keywords: Hematuria, Hamartoma, Foal

AC C

EP

TE D

M AN U

SC

RI PT

16

ACCEPTED MANUSCRIPT 1. Introduction

39

Hamartomas are non-malignant growths composed of normal tissues grouped in an unorderly

40

distribution, and their composition is dependent on the organ in which they are located. These

41

structures grow according to the normal development of the surrounding tissues, and rarely

42

develop malignant behavior; clinical relevance depends almost exclusively on the location

43

and size of the mass. They are reported frequently in humans, but seldom in domestic animals

44

[1]. The first report of hamartoma on an equine subject was made in 1981 and affected

45

ovarian tissues in a mare [2]. Other notable reports of this particular kind of lesion in equines

46

include hamartomatous myelodysplasia of the spinal cord [3], vascular hamartoma in a foal´s

47

brain [4], mesenchymal hamartoma of the liver [5], vascular hamartoma of the tongue [6],

48

subcutaneous hamartoma [7], and ovarian vascular hamartoma [8]. These previous case

49

reports stress the importance of mass location regarding clinical manifestation. The following

50

report states a previously undescribed location and clinical presentation of a vascular

51

hamartoma.

TE D

M AN U

SC

RI PT

38

52

2. Materials and methods

54

2.1 Case description

55

A 6-month-old Chilean Criollo foal was referred for evaluation of chronic hematuria and ill

56

thrift. The referring veterinarian stated that the foal presented hematuria and poor weight gain

57

since birth. No other animals were reported sick. The foal was recently weaned, kept on

58

pasture with other animals and supplemented with complete pelleted feed. The foal was not

59

dewormed nor vaccinated. The foal’s mother was reportedly healthy and had been dewormed

60

prior to parturition; the deworming product was not recorded.

AC C

EP

53

ACCEPTED MANUSCRIPT On physical examination, the patient was standing but depressed and unresponsive to external

62

stimuli. The horse had a dull and rough haircoat with abundant scaling, reddish stains on hind

63

hooves and pasterns, poor body condition (body condition score of 2 out of 9 and a body

64

weight of 120 kilograms), tachycardia (91 BPM), a grade 3/6 soft holosystolic murmur and

65

very pale mucous membranes with delayed capillary refill time (3 seconds). PCV was 9% and

66

total solids 63 g/L. Rectal temperature was 38°C and respiratory rate was 12 breaths/minute.

67

Abdominal sounds were reduced in the upper left quadrant, the rest presenting normal

68

borboygmi. Upon examination of the urinary tract, the foal was observed to urinate freely,

69

without signs of stranguria nor dysuria, and frank blood was observed throughout all stages of

70

micturition; fresh blood clots were expelled towards the end of urination. No evident lesions

71

were identified in prepuce or penis, and no active bleeding was observed. Due to the severity

72

of anemia and prior to performing further diagnostics, a decision was made to perform a

73

blood transfusion. After major and minor cross-matching blood compatibility testing, 3 liters

74

of whole blood were transfused. This procedure increased the foal’s PCV to 24% and

75

corrected most of the altered physiological constants, also eliminating the systolic murmur.

76

After initial stabilization, and in order to explore the cause of hematuria, a battery of

77

diagnostic tests was ordered. Blood coagulation tests (PT, PTT) ruled out current

78

coagulopathies. Hematologic and serum biochemical examination were performed to evaluate

79

the foal´s systemic status, revealing severe normochromic microcytic anemia prior to the

80

blood transfusion: red blood cell count was markedly reduced (2.25x10^6µL; reference range

81

5.9-9.4 x10^6µL), with minimal microcytosis (40 fL; reference range 40-61 fL) and severe

82

reduction of hemoglobin (30 g/L; reference range 107-167 g/L). Serum proteins were

83

moderately reduced (56 g/L; reference range 68-84 g/L). Serum fibrinogen results were

84

mildly increased (7 g/L; reference range <5 g/L). The leukogram revealed mild leukopenia

85

(4300 cells/µL; reference range 5000-11000 cells/ µL) with normal neutrophil count (3225

AC C

EP

TE D

M AN U

SC

RI PT

61

ACCEPTED MANUSCRIPT cells/ µL; reference range 2200-6100 cells/ µL) and marked lymphopenia (774 cells/ µL;

87

reference range 1500-6500 cells/ µL). There were no significant findings in serum

88

biochemistry analyses; urea and creatinine were within normal ranges. A spontaneously-

89

occurring midstream urine sample was obtained. Urinalysis revealed a specific gravity of

90

1.032 possibly due to mild dehydration, with abundant presence of red blood cells (>100 per

91

field), proteins (1 g/L), and a pH value of 5.

92

2.3 Diagnostic Imaging

93

Transabdominal urinary tract ultrasonography revealed no visible abnormalities of the urethra

94

or the explorable portion of the bladder. Transrectal ultrasonography was not feasible on

95

account of the foal’s size. Renal ultrasonography revealed mild size increase of both kidneys

96

(approximately 5%) compared to a healthy foal of the same age, size and breed which was

97

examined at the same time for comparison purposes. The cranio-caudal length of the left

98

kidney was 10.5 cm, and the right kidney measured 12 cm. These dimensions were relatively

99

similar to published information from 6-month-old foals of other, larger breeds (Quarter

TE D

M AN U

SC

RI PT

86

horse, Thoroughbred and Standardbred) (left kidney length reference range 14.79-16.87 cm;

101

right kidney length reference range 10.7-11.77 cm) [9]. Subjective evaluation of the right

102

renal parenchyma suggested a hyperechogenic interphase between the renal cortex and

103

medulla. The left renal parenchyma had no visible abnormalities. Doppler examination of

104

both kidneys revealed no obvious vascular abnormalities such as enlarged/varicose vessels,

105

sinuses, or blood-filled cavities.

106

Lower urinary tract endoscopy was performed with a 4 mm fiberendoscopea, under standing

107

sedation, to locate and visualize the site of bleeding. There were visible clots of blood in the

108

bladder lumen and intermittently throughout the urethra, which demanded bladder lavage with

109

sterile saline solution to clean the urinary tract and facilitate its exploration. There were no

AC C

EP

100

ACCEPTED MANUSCRIPT obvious lesions in the visible lateral and dorsal bladder walls, nor along the urethra. The

111

ureteral openings were not directly observable during standing endoscopy due to limited

112

maneuverability of the small diameter endoscope used, but no clots or blood were detected on

113

the dorsal aspect of the bladder. This procedure was performed on two different occasions, 7

114

days apart, with the same results.

115

2.4 Treatment and Outcome

116

Given the lack of a clear diagnosis, no noticeable distal urinary tract lesions, and persistent

117

hematuria, a tentative diagnosis of idiopathic renal hematuria was made. Therefore, an

118

empirical treatment course of dexamethasone (0.1 mg/kg [0.045 mg/lb], IV, q 24 h) was

119

initiated [10] to rule out an autoimmune component of disease. Ancillary treatment included

120

sodium ceftiofur (2.2 mg/kg [0.99 mg/lb], IM, q 24 h), formalin (10%, 5 Ml, IV, q 24 h) and a

121

commercial enteral multi-mineral and iron supplement. However, the foal did not improve

122

and hematuria did not change its frequency or volume. Due to the lack of response to

123

treatment in the successive days, a second blood transfusion was warranted, raising the PCV

124

from 14% to 28% (day 7 after admission). A definitive antemortem diagnosis of the cause of

125

hematuria could not be reached, and humane euthanasia was decided due to continued

126

worsening; the foal was euthanized on day 18 with a PCV of 10%.

127

3. Results:

128

3.1 Postmortem Findings

129

A full necropsy was performed. The urinary tract was fully inspected and sampled routinely.

130

A multinodular, 1.5 cm in diameter, reddish growth was observed on the dorso-lateral region

131

of the proximal urethra, immediately distal to the vesical trigone and connected with a small

132

area of bleeding in the urethral mucosa of approximately 3 mm in length (Figures 1 and 2).

133

Microscopic examination of the mass showed multiple blood-filled vascular vessels of

AC C

EP

TE D

M AN U

SC

RI PT

110

ACCEPTED MANUSCRIPT different sizes and lined by a single layer of endothelial cells. The blood vessels were

135

separated by abundant connective tissue stroma (Figure 3). Abundant acute hemorrhage was

136

visible adjacent to some vessels.

137

No other significant findings were identified on the remaining systems.

RI PT

134

AC C

EP

TE D

M AN U

SC

138

ACCEPTED MANUSCRIPT 4. Discussion:

140

This report characterizes an infrequent and previously unreported urinary tract lesion, with a

141

relevant clinical presentation and eventually fatal clinical outcome. The cardinal clinical sign

142

of this case was ill thrift and hematuria, evidenced macroscopically as urine discoloration.

143

Urine discoloration can be diagnostically challenging for equine clinicians (especially in field

144

practice), and may be classified in categories according to, for example, the molecules

145

involved (myoglobin, hemoglobin, bilirubin), the presence and amount of red blood cells

146

present in the urine (microscopic or macroscopic hematuria), or moment of discoloration

147

within micturition (initial, mid-, or terminal hematuria). Visible strands of blood in the urine

148

stream suggest a bleeding point in the urethra, thus not allowing blood to fully mix with urine,

149

as opposed to hematuria originated from lesions in the kidneys, ureters, or bladder, in which

150

blood is homogenously mixed with urine. Hematuria in the equine patient is a clinical sign

151

associated with well described disorders such as congenital malformations, urolithiasis,

152

neoplasia, intoxications (such as cantharidin), trauma, or urinary tract infections.

153

Hemospermia caused by rents communicating the urethral wall with the corpus spongiosum

154

penis also involves a connection between a vascular structure and the urethral lumen [11, 12].

155

Urethral rents are attributed to the anatomical distribution of the urethra in ischial arch, where

156

a narrowing of the diameter may influence a strain on urethral tissues, leading to a rupture and

157

communication with the corpus spongiosum penis. Hematuria is more often presented in

158

geldings than in stallions due to increased intracavernosal pressure [11]. In the case reported

159

here, although fiberendoscopic evaluation was performed twice following current

160

examination protocols, no diagnostic images were obtained on either occasion. This suggests

161

that some defects are not readily identifiable depending on the diameter of the lesion,

162

equipment limitations (such resolution, display size), and/or operator experience. In this case,

163

the communication between the hamartoma and the urethral lumen was very small (3 mm),

AC C

EP

TE D

M AN U

SC

RI PT

139

ACCEPTED MANUSCRIPT which impeded its visualization during urethral endoscopy. Moreover, the case was

165

particularly difficult to explore endoscopically due to the size of the foal, which impeded the

166

use of a 12 mm video endoscope with two-dimensional guidewires, situation that also made

167

the distension of the bladder more troublesome. Therefore, ancillary imaging techniques

168

would be necessary in these rare cases to pinpoint such a focalized lesion.

169

Periurethral structures are difficult to evaluate, especially the proximal and middle portions of

170

the urethra located inside the pelvic cavity. Transrectal ultrasonography could offer insight

171

into the status of proximal urethral structures and peripheral tissues in male patients, although

172

patients´ size may impede this maneuver. In this pediatric case, the foal´s size impeded

173

transrectal ultrasonography which could well have evidenced a periurethral mass. Previous

174

reports of bladder growths in humans have also described diagnostic difficulties, and even

175

cases of diagnosis at surgery [13]. In human medicine, bladder hamartomas are considered

176

rare entities, but have been described in pediatric and adult patients [14-18]. Clinical signs

177

may vary from painless hematuria to dysuria, and treatments have included transurethral

178

resection or partial cystectomy [15]. Similar surgical approaches may potentially be useful in

179

equine cases depending on mass size, location and patient size.

180

In conclusion, we propose that the presence of vascular hamartomas in the periphery of the

181

urinary tract should be considered as a differential diagnosis for refractory hematuria of

182

unknown/indeterminate origin.

184

185

SC

M AN U

TE D

EP

AC C

183

RI PT

164

ACCEPTED MANUSCRIPT 186

Acknowledgments:

187

The authors declare no conflicts of interest.

188

Footnotes:

190

a. Broncho-Fiberscope 60003VB1, KARL STORZ GmbH, Tuttlingen, Germany.

RI PT

189

SC

191

References:

193

[1] Bartyzel BJ, Max A, Gruszczyńska J, et al. Hamartoma: a rare developmental disorder.

194

Med Weter 2017;73:202–207.

195

[2] Rhyan JC, D’Andrea GH, Smith LS. Congenital ovarian vascular hamartoma in a horse.

196

Vet Pathol 1981;18:131.

197

[3] Taylor KR, MacKay RJ, Nelson EA, et al. Spinal cord hamartomatous myelodysplasia in

198

2 horses with clinical neurologic deficits. Vet Pathol 2016;53:844–846.

199

[4] Borel N, Grest P, Junge H, Wehrli Eser M. Vascular hamartoma in the central nervous

200

system of a foal. J Vet Diagn Invest 2014; 26:805-809.

201

[5] Brown DL, Anderson M, Cullen JM. Mesenchymal hamartoma of the liver in a late-term

202

equine fetus. Vet Pathol 2007;44:100–102.

203

[6] Brunson BL, Taintor J, Newton J, et al. Vascular hamartoma in the tongue of a horse. J

204

Equine Vet Sci 2006;26:275–277.

205

[7] Saifzadeh S, Derakhshanfar A, Shokouhi F, et al. Vascular hamartoma as the cause of

206

hind limb lameness in a horse. J Vet Med Ser A Physiol Pathol Clin Med 2006;53:202–204.

AC C

EP

TE D

M AN U

192

ACCEPTED MANUSCRIPT [8] Foley GL, Johnson R. A congenital interstitial cell hamartoma of the equine ovary. Vet

208

Pathol 1990;27:364–366.

209

[9] Aleman M, Gillis CL, Nieto JE, Renaudin CD, Bea J. Ultrasonographic anatomy and

210

biometric analysis of the thoracic and abdominal organs in healthy foals from birth to age 6

211

months. Equine Vet J 2002;34:649-55.

212

[10] Vits L, Araya O, Bustamante H, et al. Idiopathic renal haematuria in a 15-year-old

213

Arabian mare. Vet Rec 2008;162:251–252.

214

[11] Schumacher J, Schumacher J, Schmitz D. Macroscopic haematuria of horses. Equine Vet

215

Educ 2002;14:201–210.

216

[12] Schott HC. Hematuria. In: Reed SM, Bayly WM, Sellon DC, editors. Equine Internal

217

Medicine, 3rd ed. St. Louis: Saunders Elsevier, 2012, p. 1209–1213.

218

[13] Susset J, Korzinstone C, Masse S. Cavernous Hemangioma Of Vesical Neck. Urology

219

1981;17:75–76.

220

[14] Brancatelli G, Midiri M, Sparacia G, Martino R, Rizzo G, Lagalla R. Hamartoma of the

221

urinary bladder: case report and review of the literature. Eur Radiol 1999;9:42–4.

222

[15] Ota T, Kawai K, Hattori K, Uchida K, Akaza H, Harada M. Hamartoma of the urinary

223

bladder. Int J Urol 1999;6:211–214.

224

[16] Al Shahwani N, Alnaimi AR, Ammar A, Al-Ahdal EM. Hamartoma of the urinary

225

bladder in a 15-year-old boy. Turk J Urol 2016;42:101-3.

226

[17] Adam A, Gayaparsad K, Engelbrecht MJ, Moshokoa EM. Bladder hamartoma: a unique

227

cause of urinary retention in a child with Goldenhar syndrome. Saudi J Kidney Dis Transpl

228

2013;24:89-92.

AC C

EP

TE D

M AN U

SC

RI PT

207

ACCEPTED MANUSCRIPT 229

[18] Murray C, Marchan J, Özel B, Özel B. Bladder wall hamartoma: an unusual cause of

230

urinary urgency and frequency. Female Pelvic Med Reconstr Surg 2015;21:e8-e10.

231

RI PT

232

233

AC C

EP

TE D

M AN U

SC

234

ACCEPTED MANUSCRIPT Figures (in color):

236

Fig. 1 - Ventral view of the bladder and proximal urethra. Bladder (white arrowhead), urethra

237

(black arrowhead), vascular hamartoma (white arrow), opening of vascular hamartoma to the

238

urethral lumen (black arrow). Opening is approximately 3 mm wide.

239

Fig. 2 - Caudo-dorsal view of the urethra: close-up view of the lesion. Vascular hamartoma

240

(white arrow), opening to the urethral lumen (black arrow), blood clot (white arrowhead).

241

Bar = 1 cm.

242

Fig. 3 - Vascular hamartoma in the proximal urethra, horse. There are numerous blood vessels

243

of different sizes in the submucosa (arrows) separated by a connective tissue stroma (star).

244

100x; Bar = 200 µm.

AC C

EP

TE D

M AN U

SC

RI PT

235

AC C

EP

TE D

M AN U

SC

RI PT

ACCEPTED MANUSCRIPT

AC C

EP

TE D

M AN U

SC

RI PT

ACCEPTED MANUSCRIPT

AC C

EP

TE D

M AN U

SC

RI PT

ACCEPTED MANUSCRIPT

ACCEPTED MANUSCRIPT

Highlights: •

Unexplained chronic hematuria and anemia in a 6-month-old Chilean Criollo foal with ill thrift. Progressive blood loss led to humane destruction and necropsy, which revealed a

RI PT



single vascular malformation with a small communication with the urethral lumen. The infrequent etiology and location of this congenital malformation hindered

diagnostic efforts; this is the first description of a periurethral vascular hamartoma in

EP

TE D

M AN U

SC

horses.

AC C



ACCEPTED MANUSCRIPT

AC C

EP

TE D

M AN U

SC

RI PT

Animal welfare/ethical statement: The case described in this manuscript received the best available quality of medical care according to Universidad Austral de Chile´s School of Veterinary Sciences. Humane euthanasia was decided in order to avoid animal suffering. Publication was pursued with the owner´s consent.

ACCEPTED MANUSCRIPT

AC C

EP

TE D

M AN U

SC

RI PT

Conflict of interest statement: The authors declare no conflicts of interest.